Patient characteristics
| Total (N=960) | Fatal/non-fatal AMI positive at 30 days (N=80) | TRUST ADP intermediate/high risk (N=578) | TRUST ADP low risk (N=382) | |
|---|---|---|---|---|
| Age, years (Mean±SD) | 58.0±13.3 | 63.3±10.6 | 60.4±12.8 | 55.6±19.4 |
| Sex (% male) | 565 (58.9) | 53 (66.3) | 360 (62.3) | 205 (53.7) |
| Ethnicity (% British Caucasian) | 914 (95.2) | 72 (90.0) | 549 (95.0) | 365 (95.5) |
| Risk factors N (%) | ||||
| Hypertension | 452 (47.1) | 59 (73.8) | 319 (55.2) | 123 (34.8) |
| Diabetes | 164 (17.1) | 20 (25.0) | 124 (21.4) | 40 (10.5) |
| Dyslipidaemia | 635 (66.1) | 63 (78.6) | 429 (74.2) | 206 (53.9) |
| Smoking current | 231 (24.1) | 19 (23.8) | 129 (22.3) | 102 (26.7) |
| Smoker ex | 343 (35.1) | 30 (37.5) | 229 (39.6) | 114 (29.8) |
| Family history of coronary artery disease | 354 (36.9) | 29 (36.3) | 215 (37.2) | 139 (36.4) |
| Medical history | ||||
| Angina | 251 (26.1) | 29 (36.3) | 207 (35.8) | 44 (11.5) |
| Myocardial infarction | 204 (21.3) | 26 (32.5) | 174 (30.1) | 30 (7.9) |
| Percutaneous coronary intervention | 183 (19.1) | 22 (27.5) | 146 (25.3) | 37 (9.7) |
| Congestive cardiac failure | 30 (3.1) | 4 (5.0) | 25 (4.3) | 5 (1.3) |
| Atrial arrhythmia | 119 (12.4) | 8 (10.0) | 86 (14.9) | 33 (8.6) |
| Stroke | 63 (6.6) | 5 (6.3) | 45 (7.7) | 18 (4.7) |
| Coronary artery bypass graft | 50 (5.2) | 7 (8.8) | 41 (7.1) | 9 (2.4) |
| Baseline medications | ||||
| Aspirin | 361 (37.6) | 40 (50.0) | 276 (47.8) | 85 (22.3) |
| Clopidogrel | 112 (11.7) | 8 (10.0) | 84 (14.5) | 28 (7.3) |
| β blocker | 281 (29.3) | 25 (31.3) | 210 (36.3) | 71 (18.6) |
| ACE inhibitor | 272 (28.3) | 29 (36.3) | 195 (33.7) | 77 (20.2) |
| Statin | 369 (38.4) | 37 (46.3) | 276 (47.8) | 93 (24.3) |
| Median length of hospital stay (h)±IQR | 18.8±32.4 | 107.5±110.3 | 22.4±62.0 | 14.0±11.9 |
ADP, accelerated diagnostic protocol; AMI, acute myocardial infarction; TRUST, Triage Rule-out Using high-Sensitivity Troponin.